A hubXchange webinar presentation
As companion diagnostics are regulated devices, there are additional development requirements beyond those for biomarkers or clinical assays used in clinical trials. Careful consideration must be given to the regulatory strategy, design of the assay, and supporting technology platform to ensure the device can be successfully commercialized.
A hubXchange webinar panel discussion
As the world experiences unprecedented restrictions and confinement due to the SARS-Cov-2 pandemic, diagnostic testing, treatment alternatives and vaccine strategies are equally critical for different reasons.